Abstract
Summary
Glutethimide is a hypnotic sedative drug which is a safe alternative to barbiturates for treatment of insomnia. It mainly used for patients to feel sleepy and make them calm. Glutethimide is highly lipophilic and concentrates in adipose tissue and brain. It is an alternative for barbiturates. It undergoes extensive metabolism in liver with both unconjugated and conjugated metabolites which kidney excretes. Glutethimide is a CYP2D6 enzyme inducer and when it taken with codeine, it enables the body to convert high amount of codeine to morphine. The most common brand name for glutethimide are ciba, glue, and gofers. It is categorized as schedule II drug under psychotropic substances. Moreover, glutethimide is used to prevent jaundice in newborns and reduce muscle tremors.
LPI (LP Information)' newest research report, the “Glutethimide Industry Forecast” looks at past sales and reviews total world Glutethimide sales in 2022, providing a comprehensive analysis by region and market sector of projected Glutethimide sales for 2023 through 2029. With Glutethimide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glutethimide industry.
This Insight Report provides a comprehensive analysis of the global Glutethimide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glutethimide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Glutethimide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glutethimide and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glutethimide.
The global Glutethimide market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Glutethimide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Glutethimide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Glutethimide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Glutethimide players cover Pfizer, Abbott Laboratories, Mankind Pharma, Glaxosimithkine, Sanofi, Novartis, Abbvie, Bristol Mayers Squibb and Astrazeneca, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Glutethimide market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Tablets
Injection
Capsules
Segmentation by application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Abbott Laboratories
Mankind Pharma
Glaxosimithkine
Sanofi
Novartis
Abbvie
Bristol Mayers Squibb
Astrazeneca
Agilent Technologies
LPI (LP Information)' newest research report, the “Glutethimide Industry Forecast” looks at past sales and reviews total world Glutethimide sales in 2022, providing a comprehensive analysis by region and market sector of projected Glutethimide sales for 2023 through 2029. With Glutethimide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glutethimide industry.
This Insight Report provides a comprehensive analysis of the global Glutethimide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glutethimide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Glutethimide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glutethimide and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glutethimide.
The global Glutethimide market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Glutethimide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Glutethimide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Glutethimide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Glutethimide players cover Pfizer, Abbott Laboratories, Mankind Pharma, Glaxosimithkine, Sanofi, Novartis, Abbvie, Bristol Mayers Squibb and Astrazeneca, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Glutethimide market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Tablets
Injection
Capsules
Segmentation by application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Abbott Laboratories
Mankind Pharma
Glaxosimithkine
Sanofi
Novartis
Abbvie
Bristol Mayers Squibb
Astrazeneca
Agilent Technologies
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Glutethimide Market Size 2018-2029
2.1.2 Glutethimide Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Glutethimide Segment by Type
2.2.1 Tablets
2.2.2 Injection
2.2.3 Capsules
2.3 Glutethimide Market Size by Type
2.3.1 Glutethimide Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Glutethimide Market Size Market Share by Type (2018-2023)
2.4 Glutethimide Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Online Pharmacy
2.5 Glutethimide Market Size by Application
2.5.1 Glutethimide Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Glutethimide Market Size Market Share by Application (2018-2023)
3 Glutethimide Market Size by Player
3.1 Glutethimide Market Size Market Share by Players
3.1.1 Global Glutethimide Revenue by Players (2018-2023)
3.1.2 Global Glutethimide Revenue Market Share by Players (2018-2023)
3.2 Global Glutethimide Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Glutethimide by Regions
4.1 Glutethimide Market Size by Regions (2018-2023)
4.2 Americas Glutethimide Market Size Growth (2018-2023)
4.3 APAC Glutethimide Market Size Growth (2018-2023)
4.4 Europe Glutethimide Market Size Growth (2018-2023)
4.5 Middle East & Africa Glutethimide Market Size Growth (2018-2023)
5 Americas
5.1 Americas Glutethimide Market Size by Country (2018-2023)
5.2 Americas Glutethimide Market Size by Type (2018-2023)
5.3 Americas Glutethimide Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Glutethimide Market Size by Region (2018-2023)
6.2 APAC Glutethimide Market Size by Type (2018-2023)
6.3 APAC Glutethimide Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Glutethimide by Country (2018-2023)
7.2 Europe Glutethimide Market Size by Type (2018-2023)
7.3 Europe Glutethimide Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Glutethimide by Region (2018-2023)
8.2 Middle East & Africa Glutethimide Market Size by Type (2018-2023)
8.3 Middle East & Africa Glutethimide Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Glutethimide Market Forecast
10.1 Global Glutethimide Forecast by Regions (2024-2029)
10.1.1 Global Glutethimide Forecast by Regions (2024-2029)
10.1.2 Americas Glutethimide Forecast
10.1.3 APAC Glutethimide Forecast
10.1.4 Europe Glutethimide Forecast
10.1.5 Middle East & Africa Glutethimide Forecast
10.2 Americas Glutethimide Forecast by Country (2024-2029)
10.2.1 United States Glutethimide Market Forecast
10.2.2 Canada Glutethimide Market Forecast
10.2.3 Mexico Glutethimide Market Forecast
10.2.4 Brazil Glutethimide Market Forecast
10.3 APAC Glutethimide Forecast by Region (2024-2029)
10.3.1 China Glutethimide Market Forecast
10.3.2 Japan Glutethimide Market Forecast
10.3.3 Korea Glutethimide Market Forecast
10.3.4 Southeast Asia Glutethimide Market Forecast
10.3.5 India Glutethimide Market Forecast
10.3.6 Australia Glutethimide Market Forecast
10.4 Europe Glutethimide Forecast by Country (2024-2029)
10.4.1 Germany Glutethimide Market Forecast
10.4.2 France Glutethimide Market Forecast
10.4.3 UK Glutethimide Market Forecast
10.4.4 Italy Glutethimide Market Forecast
10.4.5 Russia Glutethimide Market Forecast
10.5 Middle East & Africa Glutethimide Forecast by Region (2024-2029)
10.5.1 Egypt Glutethimide Market Forecast
10.5.2 South Africa Glutethimide Market Forecast
10.5.3 Israel Glutethimide Market Forecast
10.5.4 Turkey Glutethimide Market Forecast
10.5.5 GCC Countries Glutethimide Market Forecast
10.6 Global Glutethimide Forecast by Type (2024-2029)
10.7 Global Glutethimide Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Glutethimide Product Offered
11.1.3 Pfizer Glutethimide Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Information
11.2.2 Abbott Laboratories Glutethimide Product Offered
11.2.3 Abbott Laboratories Glutethimide Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Abbott Laboratories Main Business Overview
11.2.5 Abbott Laboratories Latest Developments
11.3 Mankind Pharma
11.3.1 Mankind Pharma Company Information
11.3.2 Mankind Pharma Glutethimide Product Offered
11.3.3 Mankind Pharma Glutethimide Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Mankind Pharma Main Business Overview
11.3.5 Mankind Pharma Latest Developments
11.4 Glaxosimithkine
11.4.1 Glaxosimithkine Company Information
11.4.2 Glaxosimithkine Glutethimide Product Offered
11.4.3 Glaxosimithkine Glutethimide Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Glaxosimithkine Main Business Overview
11.4.5 Glaxosimithkine Latest Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Glutethimide Product Offered
11.5.3 Sanofi Glutethimide Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Sanofi Main Business Overview
11.5.5 Sanofi Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Glutethimide Product Offered
11.6.3 Novartis Glutethimide Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Abbvie
11.7.1 Abbvie Company Information
11.7.2 Abbvie Glutethimide Product Offered
11.7.3 Abbvie Glutethimide Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Abbvie Main Business Overview
11.7.5 Abbvie Latest Developments
11.8 Bristol Mayers Squibb
11.8.1 Bristol Mayers Squibb Company Information
11.8.2 Bristol Mayers Squibb Glutethimide Product Offered
11.8.3 Bristol Mayers Squibb Glutethimide Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Bristol Mayers Squibb Main Business Overview
11.8.5 Bristol Mayers Squibb Latest Developments
11.9 Astrazeneca
11.9.1 Astrazeneca Company Information
11.9.2 Astrazeneca Glutethimide Product Offered
11.9.3 Astrazeneca Glutethimide Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Astrazeneca Main Business Overview
11.9.5 Astrazeneca Latest Developments
11.10 Agilent Technologies
11.10.1 Agilent Technologies Company Information
11.10.2 Agilent Technologies Glutethimide Product Offered
11.10.3 Agilent Technologies Glutethimide Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Agilent Technologies Main Business Overview
11.10.5 Agilent Technologies Latest Developments
12 Research Findings and Conclusion